Community Impact
On March 17, a Dutch biotechnology delegation, organized by the Netherlands Innovation Network China and led by Antoni Mandemaker, Deputy Consul General of the Kingdom of the Netherlands in Guangzhou, visited the BGI Center, the global headquarters of BGI Group. The delegation engaged in high-lev...
Learn detailsCommunity Impact
AI empowers healthier lifestyles through personalized wellness, exercise, nutrition, and preventive care for a happier future. (AI generated image.) “Our goal is to bring genetic testing down from its pedestal and make it an everyday tool that everyone can use easily, conveniently, a...
Learn detailsCommunity Impact
BGI Group Chairman and Co-founder Wang Jian recently led a delegation to participate in the landmark 30th Anniversary Meeting of the Bermuda Principles (“BP30”) and share the company’s latest technological breakthroughs and advocate for the spirit of open science and international cooperation. ...
Learn detailsIn Southeast Asia, where thalassemia remains highly prevalent, patients continue to face limited access to advanced gene therapy and insufficient localized manufacturing capacity. In January 2026, Hemogen Therapeutic, a subsidiary of BGI Group, successfully completed the first overse...
On February 3, Uruguay President Yamandú Orsi met with BGI Group CEO Dr. Yin Ye in Beijing to discuss the successful progress of BGI’s operations in Uruguay and explore future collaboration opportunities. Uruguay President Yamandú Orsi (left) met with BGI Group CEO Dr. Yin Ye. During ...
As of January 26, recent Nipah virus infection cases have emerged in West Bengal, eastern India, with five confirmed cases reported and nearly 100 people quarantined, including one patient in critical condition. In response, neighboring countries like Thailand and Nepal have intensified epidemic ...
Organized by BGI College and Dalian University of Technology (DUT), the 2026 DUT-BGI International Winter School commenced on January 18 at the BGI Center, the global headquarters of BGI Group. This week-long academic exchange brings together 25 young scholars and students from 11 countries, incl...
BGI Group has noted that the 2026 U.S. National Defense Authorization Act contains provisions that would restrict certain Chinese biotechnology companies from conducting business in the United States. Such restrictions could limit U.S. entities’ ability to choose business and research part...
Two global scientific collaboration projects initiated by BGI Group – the Human Genome Project II (HGP2), and the African Microbiome Consortium for Infectious Diseases (AMC-ID) - were recently selected for endorsement by the United Nations Educational, Scientific and Cultural Organization (UNESCO...